David Dimmock, MD
Senior Medical Director, Rady Children’s Institute for Genomic Medicine, San Diego, CA, USA
Dr. David Dimmock is an internationally renowned expert in the field of clinical genomic medicine and is passionate about improving the standard of care for children and adults with inborn errors of metabolism. Through 20 years of clinical experience, his medical practice has become focused on the identification of rare disorders through newborn screening and advanced genomic techniques. He is especially recognized for bringing innovative diagnostic testing strategies into the clinic. After graduating from St George’s (University of London), Dr. Dimmock undertook training in pediatrics in the UK. With a passion for adult and pediatric metabolic diseases, he began a US pediatric residency program in Phoenix, Arizona. He then undertook Genetics and Clinical Metabolic Genetics fellowship training at Baylor College of Medicine (BCM) in Houston, Texas. After a faculty appointment at BCM he moved on to the Medical College of Wisconsin becoming an Associate Professor of Pediatrics and the Chair of the State of Wisconsin newborn screening metabolic disease subcommittee. In June 2016, he started his current post as the medical director of the Rady Children’s Institute for Genomic Medicine. Dr. Dimmock has been an invited advisor to the FDA, CDC and the Institute of Medicine. In addition to substantive NIH grants, he has been the Principal investigator on more than 20 clinical trials of novel therapeutics in rare metabolic diseases.
The Medical Genome Initiative ©2021. All Rights Reserved.